Symptoms of Alzheimer’s disease may be working on individual’s way before actual symptoms emerges- Study Reveals

Years before the symptoms appeared in patients, biomarkers could detect the development of Alzheimer’s according to a new study. It was found that the changes that take place in individuals during midlife in the spinal fluid may be of assistance in identifying people who are at risk of developing this disease as they become older. This allows doctors to treat patients’ way ahead of time before the patients show any signs of memory loss or other cognitive issues.

Researchers from Washington University in St. Louis (WUSTL) who has carried out the study have announced that this could be helping them to construct biomarkers which be predicting the Alzheimer’s in people.

Anne Fagan, senior author of the study and a professor of neurology has said, “It’s too early to use these biomarkers to definitively predict whether individual patients will develop Alzheimer’s disease, but we’re working toward that goal.”

This disease is another common kind of dementia and it destroys the part of the brain responsible for controlling thoughts, memories and languages in a gradual manner. This makes is impossible for patients to conduct a proper conversation and live independently.

There are cases where younger people may also be developing Alzheimer’s but usually the symptoms first appears after the age of 60 and with age the risk of the disease just augments.

What are the actual causes of the Alzheimer’s disease is something scientists are still not aware of but it is suspected by them that there is something to do with the process which triggers the build-up of clumped and tangled proteins that are present the people’s brain who have been affected by this disease and eventually died of it too.

There are about 5 million Americans who are living with this disease according to the Centers for Disease Control and Prevention.

Researchers have gathered 10 years worth of data from 16 people with an age range of 45 to 75 who had been cognitively healthy are the time they signed up for participating on the study. These people have been sectioned in 3 groups, early-middle age (45-54 years), mid-middle age (55-64) and late-middle age (65-74).

The study findings have been published in JAMA Neurology.